Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2012-12-20 Regulatory Filings
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Allotment of acquisition cost decided by the Swedish Tax Agency
Regulatory Filings Classification · 95% confidence The document is a short press release dated December 20, 2012, announcing a decision made by the Swedish Tax Agency regarding the allotment of acquisition cost following a distribution of shares (Vitrolife distributing Xvivo Perfusion AB shares). This is a specific corporate action announcement related to tax implications following a corporate event, not a standard financial report (like 10-K, IR, ER) or a management/board change. It is a regulatory disclosure required under Swedish law ('Securities Market Act'). Since it doesn't fit into specific categories like Capital/Financing (CAP), Director's Dealing (DIRS), or Major Shareholding (MRQ), and it is a general regulatory announcement, the most appropriate fallback category is Regulatory Filings (RNS). The document length is short (2441 chars) and it is a direct announcement, not an announcement *of* a larger report.
2012-12-20 English
Vitrolifes aktiekapital och antal aktier per den 30 november 2012
Share Issue/Capital Change Classification · 98% confidence The document is a press release dated November 30, 2012, titled "Vitrolifes aktiekapital och antal aktier per den 30 november 2012" (Vitrolife's share capital and number of shares as of November 30, 2012). It explicitly details changes in the total number of outstanding shares (an increase of 268,167 shares due to an emission related to an acquisition) and the resulting share capital. This content directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). It is not a general earnings release (ER), a full annual report (10-K), or a dividend notice (DIV).
2012-11-30 Swedish
Vitrolife’s share capital and number of shares on November 30, 2012
Share Issue/Capital Change Classification · 98% confidence The document is a short press release dated November 30, 2012, detailing an update to the company's total number of shares and share capital. It explicitly mentions an increase in shares due to a private placement related to an acquisition. This type of announcement, focusing on changes to the number of outstanding shares or capital structure, directly corresponds to the 'Share Issue/Capital Change' definition. Therefore, the appropriate code is SHA.
2012-11-30 English
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is titled 'delårsrapport' (Interim Report) for Vitrolife AB for the period January-September 2012. It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business performance. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it is classified as an Interim/Quarterly Report. 9M 2012
2012-11-01 Swedish
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is titled 'interim report january-september 2012' and contains comprehensive financial statements, including income statements, cash flow analysis, and management commentary for the specified period. It is a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). 9M 2012
2012-11-01 English
Riktad nyemission rörande Cryo Management fulltecknad
Capital/Financing Update Classification · 98% confidence The document is a press release dated October 31, 2012, announcing that a directed share issue ('Riktad nyemission') related to the acquisition of Cryo Management has been fully subscribed. The text details the decision by the Extraordinary General Meeting and the subsequent board resolution regarding the increase in share capital and the number of new shares issued. This directly relates to changes in the company's capital structure and fundraising activities. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an interim report (IR), or just a dividend notice (DIV).
2012-10-31 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.